Ducommun Incorporated revealed an error in its historical financial statements related to stock-based compensation timing, leading to a 3% share price drop. The company stated that financial reports from 2024 and 2025 should no longer be trusted. This has triggered an investigation by the Schall Law Firm into potential securities law violations, including misleading statements or failure to disclose important information. Investors who suffered losses are encouraged to contact the law firm to discuss their rights and possible legal action.
Johnson & Johnson announced that the Phase 3 MonumenTAL-3 study demonstrated that TALVEY (talquetamab) combined with daratumumab, with or without pomalidomide, significantly improved progression-free survival (up to 81.3%) and overall survival (up to...
This week, retail investors showed strong interest in five stocks: SpaceX, Micron Technology, Advanced Micro Devices (AMD), Uber Technologies, and Super Micro Computer. SpaceX shares surged after its IPO, closing 19.3% higher on the first day. Micron...
FREELANDER 8 made its first public appearance at the Abu Dhabi Investment Forum in Shanghai, ahead of its official launch in Abu Dhabi. The vehicle, a premium intelligent all-terrain SUV co-created by Jaguar Land Rover and Chery, targets the Middle E...
SpaceX's historic market debut valued the company at about $2.1 trillion, sparking massive retail interest and record traffic on Robinhood. Jim Cramer predicts this could accelerate AI-related stock offerings, with companies like Anthropic potentiall...
Several credit cards are offering attractive welcome bonuses and travel perks for summer 2026. The American Express Platinum Card features up to 175,000 Membership Rewards points after spending $12,000 in six months, along with extensive travel credi...
